Abstract
A carotid body tumor (CBT) is a rare highly vascular tumor. Therefore, the assessment of the tumor’s vessels preoperatively is significant to decrease the risk of vascular complications intraoperatively. We report a case of carotid body tumor in a 40-year-old female who presented with a headache and a pulsatile right neck mass. She underwent computed tomography (CT), which demonstrated a well-circumscribed tumor mass measuring 3 X 2.7 X 3.6 cm. Preoperatively, selective embolization was performed in which Onyx 18 (Medtronic, Dublin, Ireland) and precipitating hydrophobic injectable liquid (PHIL) 25% (Microvention Inc, California) were used, and that achieved 95% embolization of tumor blood supply. One day after embolization, complete surgical resection was done by a multidisciplinary team.
Keywords: carotid body tumor, multidisciplinary approach, selective embolization, preoperative embolization
Introduction
A carotid body tumor (CBT) is a rare neuroendocrine neoplasm, arising from the chemoreceptor cells of the carotid bulb. Around 35% of carotid body tumors are hereditary; malignant tumors account for 5%-7% of CBTs and the greatest risk is in young patients with familial tumors. An asymptomatic lateral neck mass is the usual presentation of CBTs, commonly in patients between the fifth and seventh decades. Other complaints can be nonspecific such as a sense of tightness in the neck, stiffness, or neck tenderness; rarely, patients present with symptoms related to endocrine hormone release such as palpitation, headache, diaphoresis, dizziness, and flushing [1-2].
With time, the size of CBTs may increase, leading to the invasion of the adjacent neurovascular structure. Consequently, the morbidity and complications of surgical resection rise. Therefore, the Shamblin classification has been developed to predict the difficulties and complications for surgical resection by describing the tumor in relation to the blood vessels. There are three groups: I, the tumor is less than 5 cm and relatively free of vessel involvement; II, the tumor is intimately involved but does not encase the vessel wall; and III, the tumor is intramural and encases the carotid vessels and adjacent nerves.
Imaging studies are important to confirm the diagnosis and delineate the relationship to the adjacent structure. However, localization of the tumor to the carotid bifurcation can be done by carotid duplex scan [3].
Assessment of the vessel's invasion and intracranial circulation using arteriography gives the benefit for preoperative embolization of the feeder vessels, which has shown to reduce intraoperative blood loss, better tumor visualization, and tumor shrinkage. In theory, preoperative embolization decreases the risk of stroke and neurological morbidity [3-5].
The recommended treatment of CBTs is surgical resection, and the importance of a multidisciplinary team approach has been reported in a cohort study that showed less morbidity and neurovascular complications despite the fact that included cases were with more advanced tumors [6].
In this paper, a case of carotid body tumor is reported, which required a multidisciplinary team to perform super-selective embolization followed by surgical resection.
Case presentation
A 40-year-old woman was admitted under neurosurgery in King Fahad University Hospital with complaints of headache and a pulsatile right neck mass for eight years. Her symptoms were associated with constant right ear pain radiating to the jaw for six months duration. She denied experiencing compressive symptoms (dysphagia, dyspnea, or change in voice) and there was no history of aspiration or limited neck motion. On physical examination, a pulsating 2x2 cm mass was observed on the right side of the neck at level II, with no limitation of neck movement. Flexible nasopharyngoscopy was performed, which revealed a clear nasopharynx, oropharynx, mobile vocal folds, and no secretion in the supraglottic area. Cranial nerves examination revealed no abnormal findings.
Investigations at admission were normal, including CBC, renal function tests (RFTs), and liver function tests (LFTs).
She underwent computed tomography (CT) scan of the neck with and without contrast, which showed a focal, rounded soft tissue mass measuring 3 X 2.7 X 3.6 cm. It was located along the right common carotid artery (CCA) bifurcation with splaying of the internal carotid artery (ICA) and external carotid artery (ECA), which was consistent with a ShamblinII Carotid body tumor (Figure 1).
Figure 1. Contrast-enhanced computed tomography demonstrated a focal, rounded soft tissue mass of size 3 X 2.7 X 3.6 cm and located along the bifurcation of the right common carotid artery with splaying of external and internal carotid artery.
Pre-resection angiogram combined with selective embolization of the feeders was performed under aseptic technique and fluoroscopic guidance, in which Onyx 18 (Medtronic, Dublin, Ireland) and precipitating hydrophobic injectable liquid (PHIL) 25% (Microvention Inc, California) were used.
A 5F sheath was inserted into the right femoral artery. A 5F vertebral catheter was used for selective catheterization of intracranial vessels. The 5F vertebral catheter was parked at the CCA proximal to the origin of the ECA. Selective runs and super-selective micro-runs were obtained to identify the optimal feeders to embolize. Using the specter C balloon microcatheter positioned at the distal occipital branch, micro-runs were taken before and during balloon inflation and while the specter balloon was inflated, Onyx 18 was injected into the feeders until reflex was observed. Then, an Echelon 14 was advanced into the distal feeder of the ascending pharyngeal branch and PHIL 25% was injected. This was followed by an Echelon 10 and PHIL 25% was injected into the main feeders from the ascending pharyngeal branch. Finally, an Echelon 14 was maneuvered into the proximal branch of the ECA, just distal to the bifurcation, and it was identified as the main feeder and serial runs were obtained; the micro-catheter was advanced into the tumor blush under roadmap guidance (Figure 2).
Figure 2. A, B: Preoperative angiography shows a vascularized CBT; C, D: Postembolization achieved devascularization of the tumor’s blood supply.
CBT: carotid body tumor
Due to non-aspiration of back bleeding into the micro-catheter, it was retracted more proximally sequentially till the proximal end of the feeding artery, at which point a control run showed no flow in the distal feeder and non-visualization of the tumor blush most likely due to spasm. This was maintained at control runs of 15 minutes. Control runs showed embolization of 95% of the carotid body tumor supply with few direct small feeders into the remaining tumor blush and no change in the control right ICA runs.
Hemostasis was maintained by compression for 20 minutes and then the patient was shifted to the intensive care unit. A postembolization evaluation revealed a pulsating, localized right neck mass with no sensorimotor deficits and intact cranial nerves.
To achieve complete resection with minimal neurovascular compromise, the surgical procedure was performed by a multidisciplinary team composed of ear, nose, throat (ENT) surgeons, neurosurgeons, and vascular surgeons. The neck was explored by a 6 cm horizontal incision under general anesthesia one day after the embolization. Intraoperatively, right neck dissection and surgical resection of the right carotid body tumor were done with preservation of internal and external carotid arteries. A drain was placed in the surgical site, and the wound was closed in layers.
The postoperative course was uneventful, and her post-resection CT of the neck with contrast demonstrated non-organized fluid density seen at the surgical bed with no evidence of an enhancing residual mass in the right carotid space (Figure 3). Three days postoperatively, she was discharged with no active complaints.
Figure 3. Post-surgical resection computed tomography.
Discussion
A carotid paraganglioma is the most common head and neck tumor; over 65% of paragangliomas are CBTs. However, most CBTs are non-functional vascular neoplasms and mainly present with a slow-growing cervical mass. Therefore, duplex ultrasound is recommended as an effective diagnostic tool while a CT scan and other imaging studies are important for presurgical assessment [7].
Complete surgical resection of CBT remains the treatment of choice. However, advanced carotid body tumors are challenging to resect due to the high risk of significant bleeding intraoperatively. Consequently, that will affect the surgical outcome and the risk of neurovascular complications. Therefore, the importance of selective preoperative embolization to occlude the tumor’s feeders has been supported in a retrospective study and its surgical results were significant between the two groups, which include less amount of blood loss and shorten the operative time in the embolization group. There was no difference in the incidence of cranial nerve injury. However, embolization might lead to intense local inflammation, which necessitated reducing the surgical interval between embolization and resection [8].
Onyx is a non-adhesive liquid embolic agent, which has been used in several reported cases of paragangliomas. A direct intralesional embolization with 20 ml of Onyx was performed preoperatively in a 20-year-old woman with a carotid body tumor of Shamblin class III until devascularization was achieved. Intraoperatively, there was minimal bleeding, which facilitates complete CBT resection with the preservation of common carotid, internal, and external carotid arteries. However, the patient showed symptoms of Horner syndrome and deficits of the hypoglossal and glossopharyngeal nerves [9].
In this case report, we have performed selective pre-resection embolization using two liquid embolic agents, Onyx 18 and PHIL 25%, which achieved an embolization of 95% of the carotid body tumor supply. Postembolization, there were no neurovascular complications or evidence of cranial nerve involvement or sensorimotor deficits. Intraoperatively, complete CBT resection has been achieved with the preservation of internal and external carotid arteries.
Conclusions
We report a case of carotid body tumor who underwent preoperative selective embolization by Onyx 18 and Phil 25% followed by complete surgical resection by a multidisciplinary team. Using these agents achieved 95% of tumor devascularization without worsening symptoms and complications. Therefore, based on this experience, we recommend the use of Onyx 18 to achieve optimal treatment for CBT. However, further studies must be conducted to prove the efficacy of Onyx in the management of carotid paraganglioma.
The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.
The authors have declared that no competing interests exist.
Human Ethics
Consent was obtained or waived by all participants in this study
References
- 1.Brunicardi C, Andersen DK, Billiar TR, et al. Schwartz's Principles of Surgery. New York: McGraw-Hill; 2019. [Google Scholar]
- 2.Adjunct endovascular interventions in carotid body tumors. Economopoulos K, Tzani A, Reifsnyder T. J Vasc Surg. 2015;61:1081–1091. doi: 10.1016/j.jvs.2015.01.035. [DOI] [PubMed] [Google Scholar]
- 3.Endoarterial management of dural arteriovenous malformations with isolated sinus using Onyx-18: technical case report. de Paula Lucas C, Mounayer C, Spelle L, Piotin M, Rezende MT, Moret J. Oper Neurosurg. 2007;61:293–294. doi: 10.1227/01.neu.0000303981.34622.39. [DOI] [PubMed] [Google Scholar]
- 4.Superselective carotid body tumor embolization with platinum-based coils. Bellamkonda KS, Chen JF, Tonnessen B, Rahmati R, Nassiri N. J Vasc Surg Cases Innov Tech. 2020;[Epub ahead of print] doi: 10.1016/j.jvscit.2020.10.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Preoperative embolization in carotid body tumor surgery: is it required? Zeitler DM, Glick J, Har-El G. Ann Otol Rhinol Laryngol. 2010;119:279–283. doi: 10.1177/000348941011900501. [DOI] [PubMed] [Google Scholar]
- 6.The outcome of multidisciplinary management of carotid body tumors: retrospective cohort study. Hassanein AG, Hassanein KA-A. M, Fadle KN, Al-Eslam AS, Al Qahtani FN. J Maxillofac Oral Surg. 2019;18:610–616. doi: 10.1007/s12663-018-1176-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.The carotid body and associated tumors: updated review with clinical/surgical significance. Butt N, Baek WK, Lachkar S, et al. Br J Neurosurg. 2019;33:500–503. doi: 10.1080/02688697.2019.1617404. [DOI] [PubMed] [Google Scholar]
- 8.Impact of preoperative transarterial embolization of carotid body tumor: a single center retrospective cohort experience. Zhang J, Fan X, Zhen Y, et al. Int J Surg. 2018;54:48–52. doi: 10.1016/j.ijsu.2018.04.032. [DOI] [PubMed] [Google Scholar]
- 9.Early side effects after embolization of a carotid body tumor using Onyx. Wiegand S, Kureck I, Chapot R, Sesterhenn AM, Bien S, Werner JA. J Vasc Surg. 2010;52:742–745. doi: 10.1016/j.jvs.2010.04.026. [DOI] [PubMed] [Google Scholar]



